• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 Lactococcus lactis 口服递送葡萄球菌核酸酶可预防 NOD 小鼠的 1 型糖尿病。

Oral delivery of staphylococcal nuclease by Lactococcus lactis prevents type 1 diabetes mellitus in NOD mice.

机构信息

Minigene Pharmacy Laboratory, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.

出版信息

Appl Microbiol Biotechnol. 2017 Oct;101(20):7653-7662. doi: 10.1007/s00253-017-8480-5. Epub 2017 Sep 9.

DOI:10.1007/s00253-017-8480-5
PMID:28889199
Abstract

Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by the self-destruction of insulin-producing β cells. Recently, studies have revealed that neutrophils contribute to the early pathological injury to the pancreas, predominantly via the formation of neutrophil extracellular traps (NETs). To determine whether early intervention targeting NETs with staphylococcal nuclease (SNase) can delay the onset of T1DM, non-obese diabetic (NOD) mice were orally administered recombinant Lactococcus lactis (L. lactis) expressing SNase. The results showed that NETs were effectively disrupted by SNase both in vivo and in vitro, leading to a significant decrease in neutrophil-derived circulating free DNA (cf-DNA/NETs), neutrophil elastase (NE), and protease 3 (PR3) in the serum compared with the controls. In addition, SNase effectively regulated the blood glucose levels of NOD mice, and the onset of diabetes was postponed with reduced mortality and morbidity. Recombinant L. lactis also ameliorated inflammation in NOD mice, as evidenced by the remarkable increase in IL-4 and reductions in TNF-α and CRP. Moreover, HE staining results showed that L. lactis expressing SNase exerted protective effects on pancreatic islets and relieved inflammation of the small intestine in NOD mice. Hence, the present study indicates that the oral delivery of SNase by L. lactis can effectively prevent T1DM, ameliorate inflammation, and contribute to immunomodulatory balance in NOD mice.

摘要

1 型糖尿病(T1DM)是一种自身免疫性疾病,其特征是胰岛素产生β细胞的自身破坏。最近的研究表明,中性粒细胞通过形成中性粒细胞胞外诱捕网(NETs),促进胰腺的早期病理损伤。为了确定用金黄色葡萄球菌核酸酶(SNase)靶向 NETs 的早期干预是否可以延迟 T1DM 的发病,非肥胖型糖尿病(NOD)小鼠口服给予表达 SNase 的重组乳球菌(L. lactis)。结果表明,SNase 可有效在体内和体外破坏 NETs,导致与对照组相比,血清中中性粒细胞来源的循环游离 DNA(cf-DNA/NETs)、中性粒细胞弹性蛋白酶(NE)和蛋白酶 3(PR3)显著减少。此外,SNase 可有效调节 NOD 小鼠的血糖水平,降低死亡率和发病率,从而延迟糖尿病的发病。重组乳球菌还改善了 NOD 小鼠的炎症,IL-4 显著增加,TNF-α 和 CRP 减少。此外,HE 染色结果表明,表达 SNase 的乳球菌对胰岛具有保护作用,并缓解 NOD 小鼠的小肠炎症。因此,本研究表明,L. lactis 表达的 SNase 经口服给药可有效预防 T1DM,改善炎症,并有助于 NOD 小鼠的免疫调节平衡。

相似文献

1
Oral delivery of staphylococcal nuclease by Lactococcus lactis prevents type 1 diabetes mellitus in NOD mice.通过 Lactococcus lactis 口服递送葡萄球菌核酸酶可预防 NOD 小鼠的 1 型糖尿病。
Appl Microbiol Biotechnol. 2017 Oct;101(20):7653-7662. doi: 10.1007/s00253-017-8480-5. Epub 2017 Sep 9.
2
Ameliorating gut microenvironment through staphylococcal nuclease-mediated intestinal NETs degradation for prevention of type 1 diabetes in NOD mice.通过金黄色葡萄球菌核酸酶介导的肠道 NETs 降解改善肠道微环境,预防 NOD 小鼠 1 型糖尿病。
Life Sci. 2019 Mar 15;221:301-310. doi: 10.1016/j.lfs.2019.02.034. Epub 2019 Feb 16.
3
Oral delivery of staphylococcal nuclease ameliorates DSS induced ulcerative colitis in mice via degrading intestinal neutrophil extracellular traps.通过降解肠道中性粒细胞胞外诱捕网,口服葡萄球菌核酸酶可改善小鼠中由葡聚糖硫酸钠诱导的溃疡性结肠炎。
Ecotoxicol Environ Saf. 2021 Jun 1;215:112161. doi: 10.1016/j.ecoenv.2021.112161. Epub 2021 Mar 31.
4
Oral administration of Lactococcus lactis-expressing heat shock protein 65 and tandemly repeated IA2P2 prevents type 1 diabetes in NOD mice.口服表达热休克蛋白65和串联重复IA2P2的乳酸乳球菌可预防非肥胖糖尿病(NOD)小鼠患1型糖尿病。
Immunol Lett. 2016 Jun;174:28-36. doi: 10.1016/j.imlet.2016.04.008. Epub 2016 Apr 13.
5
Recombinant Carrying IL-4 and IL-10 Coding Vectors Protects against Type 1 Diabetes in NOD Mice and Attenuates Insulitis in the STZ-Induced Model.携带 IL-4 和 IL-10 编码载体的重组体可预防 NOD 小鼠的 1 型糖尿病,并减轻 STZ 诱导模型中的胰岛炎。
J Diabetes Res. 2021 Feb 2;2021:6697319. doi: 10.1155/2021/6697319. eCollection 2021.
6
Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice.口服表达HSP65和串联重复P277的重组乳酸乳球菌可降低非肥胖糖尿病小鼠I型糖尿病的发病率。
PLoS One. 2014 Aug 26;9(8):e105701. doi: 10.1371/journal.pone.0105701. eCollection 2014.
7
Immunomodulation therapy of diabetes by oral administration of a surfactin lipopeptide in NOD mice.
Vaccine. 2014 Nov 28;32(50):6812-9. doi: 10.1016/j.vaccine.2014.08.082. Epub 2014 Sep 17.
8
Inhibition of PAD4-mediated NET formation by cl-amidine prevents diabetes development in nonobese diabetic mice.氯己定通过抑制 PAD4 介导体液 NETs 形成预防非肥胖型糖尿病小鼠的糖尿病发生。
Eur J Pharmacol. 2022 Feb 5;916:174623. doi: 10.1016/j.ejphar.2021.174623. Epub 2021 Nov 9.
9
Intestinal Delivery of Proinsulin and IL-10 via Combined With Low-Dose Anti-CD3 Restores Tolerance Outside the Window of Acute Type 1 Diabetes Diagnosis.通过联合使用低剂量抗 CD3 和胰岛素原及 IL-10 经肠道给药在 1 型糖尿病诊断的急性窗口期之外恢复耐受性。
Front Immunol. 2020 Jun 9;11:1103. doi: 10.3389/fimmu.2020.01103. eCollection 2020.
10
Direct screening of recombinants in gram-positive bacteria using the secreted staphylococcal nuclease as a reporter.使用分泌型葡萄球菌核酸酶作为报告基因对革兰氏阳性菌中的重组体进行直接筛选。
J Bacteriol. 1994 Aug;176(16):5135-9. doi: 10.1128/jb.176.16.5135-5139.1994.

引用本文的文献

1
Engineering Probiotics for Diabetes Management: Advances, Challenges, and Future Directions in Translational Microbiology.工程益生菌用于糖尿病管理:转化微生物学的进展、挑战和未来方向。
Int J Nanomedicine. 2024 Oct 28;19:10917-10940. doi: 10.2147/IJN.S492651. eCollection 2024.
2
Assessing the causal relationship between gut microbiota and diabetic nephropathy: insights from two-sample Mendelian randomization.评估肠道微生物群与糖尿病肾病之间的因果关系:来自两样本孟德尔随机化的见解。
Front Endocrinol (Lausanne). 2024 Mar 18;15:1329954. doi: 10.3389/fendo.2024.1329954. eCollection 2024.
3
Engineered probiotics introduced to improve intestinal microecology for the treatment of chronic diseases: present state and perspectives.
用于改善肠道微生态以治疗慢性疾病的工程益生菌:现状与展望
J Diabetes Metab Disord. 2023 Sep 5;22(2):1029-1038. doi: 10.1007/s40200-023-01279-1. eCollection 2023 Dec.
4
Beneficial Effects of Dietary Flaxseed Oil through Inflammation Pathways and Gut Microbiota in Streptozotocin-Induced Diabetic Mice.膳食亚麻籽油通过炎症途径和肠道微生物群对链脲佐菌素诱导的糖尿病小鼠的有益作用。
Foods. 2023 Aug 28;12(17):3229. doi: 10.3390/foods12173229.
5
Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus.I 型糖尿病的免疫疗法的先进递送策略。
BioDrugs. 2023 May;37(3):331-352. doi: 10.1007/s40259-023-00594-6. Epub 2023 May 13.
6
Oral delivery of bi-autoantigens by bacterium-like particles (BLPs) against autoimmune diabetes in NOD mice.细菌样颗粒(BLPs)口服递呈双自体抗原防治 NOD 小鼠自身免疫性糖尿病。
Drug Deliv. 2023 Dec;30(1):2173339. doi: 10.1080/10717544.2023.2173339.
7
Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes.创新设计和物流考虑因素加速 1 型糖尿病联合疾病修饰治疗的临床开发。
Diabetes Care. 2022 Oct 1;45(10):2189-2201. doi: 10.2337/dc22-0308.
8
Pathogen-Derived Nucleases: An Effective Weapon for Escaping Extracellular Traps.病原体衍生的核酸酶:逃避细胞外陷阱的有效武器。
Front Immunol. 2022 Jul 5;13:899890. doi: 10.3389/fimmu.2022.899890. eCollection 2022.
9
Oral delivery of the intracellular domain of the insulinoma-associated protein 2 (IA-2ic) by bacterium-like particles (BLPs) prevents type 1 diabetes mellitus in NOD mice.细菌样颗粒(BLPs)口服递送胰岛淀粉样多肽 2(IA-2ic)的细胞内结构域可预防 NOD 小鼠 1 型糖尿病。
Drug Deliv. 2022 Dec;29(1):925-936. doi: 10.1080/10717544.2022.2053760.
10
Neutrophils in chronic inflammatory diseases.慢性炎症性疾病中的中性粒细胞。
Cell Mol Immunol. 2022 Feb;19(2):177-191. doi: 10.1038/s41423-021-00832-3. Epub 2022 Jan 17.